Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 · View on ClinicalTrials.gov ↗
Study Summary
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Conditions Studied
Study Locations (20)
California
- Children's Hospital of Los Angeles — Los Angeles
- Mattel Children's Hospital at University of California Los Angeles — Los Angeles
- Stanford University Medical Center — Palo Alto
- Rady Children's Hospital San Diego — San Diego
- University of California at San Francisco Medical Center — San Francisco
Florida
- University of Florida - Shand's Children's Hospital — Gainesville
- Nicklaus Children's Hospital — Miami
- Nemours Children's Hospital — Orlando
- Johns Hopkins All Children's Hospital — St. Petersburg
Illinois
- University of Illinois at Chicago — Chicago
- Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago
- University of Chicago Medical Center — Chicago
Connecticut
- Connecticut Children's Medical Center — Hartford
- Yale University — New Haven
Georgia
- Emory Children's Center — Atlanta
- Georgia Regents University Medical Center — Augusta
Alabama
- University of Alabama at Birmingham — Birmingham
Arizona
- Phoenix Children's Hospital — Phoenix
Colorado
- The Children's Hospital of Colorado — Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-07 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02418442
The ClinicalTrials.gov registry entry for NCT02418442 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,129 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Rheumatic Joint Disease appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02418442 reports 20 study locations spanning 9 distinct geographic areas — top geographies include California, Florida, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02418442 about?
NCT02418442 is a clinical study titled "Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry". Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions abou...
What is the current status of trial NCT02418442?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-07. Estimated completion is 2028-12.
What conditions does trial NCT02418442 study?
This clinical trial studies the following conditions: Rheumatic Joint Disease. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT02418442?
This trial is sponsored by Duke University, which has 1,129 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02418442 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.